Both in R&D — Physical & Biological Sciences
MaxCyte vs Charles River Laboratories International
Over the past year MXCT returned −13.7% and CRL returned +83.5%; their daily moves had a correlation of 0.29.
MXCT −13.7% CRL +83.5%Growth of $1, one year, split-adjusted
| Metric | MXCT | CRL |
|---|---|---|
| Price | $1.39 | $326.29 |
| Market cap | $143.5M | $15.58B |
| Today | −4.79% | −7.27% |
| 1 month | +27.5% | +7.0% |
| 6 months | +64.2% | +79.5% |
| Year to date | −10.3% | +63.6% |
| 1 year | −13.7% | +82.4% |
| Revenue growth (YoY) | −14.5% | −2.7% |
| Gross margin | 77.0% | 36.2% |
| Net margin | −122.0% | −0.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.6× | 3.9× |
| Net cash | $105.7M | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 82.3% | 44.4% |
| Short % of float | 2.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).